We seek exceptional science and extraordinary founders. The entrepreneurs we back are fluent in the languages of biology, chemistry, software, hardware, ML, and AI. Our team mirrors these founders, with technical expertise in engineering, biology, genomics, and biotechnology.
*Target Investments
Companies at the interface of technology and life sciences with a focus on software tools, artificial intelligence, machine learning, multi-omics, drug discovery, precision medicine, and tech-enabled services.
*Investment Size
Our initial checks range from $1m to $6m. We reserve for follow-on investments and aim to be a part of the company's growth.
*Stage
Our ideal entry point is Seed financing or Series A. We like to get involved early and be a core part of the team, supporting founders from day one, through the lifecycle of their company.
*Geography
We have offices in Boston, Miami, and Research Triangle Park. We invest primarily in North America and Europe and are open to other regions. We spend time with portfolio companies regardless of location.
People
- Christine Aylward, Founder & Managing Partner
You last contacted this investor on .